June 7, 2007 - Sectra, together with clinical and industrial partners, will lead a project involving six European countries on high-resolution, low-dose X-ray imaging’s role in the fight against breast cancer.
The project, known as the “High-Resolution X-Ray Imaging for Improved Detection and Diagnosis of Breast Cancer (HighReX), involves development of novel imaging methods based on Sectra´s photon-counting detector technology, which, according to the company, provides the unmatched lowest radiation dose on the market. The project’s objective is to improve early detection and diagnosis of breast cancer and clinical evaluation of the new methods. Sectra’s photon-counting detector technology is commercially available through Sectra MicroDose Mammography.
The EUR 3.6 million grant is one of the largest grants of its type ever awarded by the EU in its efforts to combat breast cancer. Experienced mammography physicians from several European breast-imaging centers are involved in the project to test and evaluate the imaging techniques developed in the project and compare them to existing methods.
Within the HighReX project, Sectra will develop and evaluate novel methods for breast cancer detection and diagnosis, such as 3D/tomosynthesis, dual-energy and contrast mammography.
July 29, 2024 
